Cardiac resynchronization therapy (CRT) is considered a beneficial and disease-modifying treatment in appropriately selected heart failure (HF) patients. It reduces morbidity and mortality, reverses ...

A small panel of circulating biomarkers may reliably distinguish hypertrophic cardiomyopathy (HCM) from similar conditions that cause left ventricular hypertrophy (LVH), researchers found. From ...